John M. Evans - CEO, Director at Beam Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
BEAM on Nasdaq
All Insider Reports
All Insider Reports

John M. Evans - trading volume in the past year for Beam Therapeutics Inc.

Holdings reported by John M. Evans for Beam Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 987K $24.3M $24.63 Oct 2, 2025 Direct
Stock Option (Right to Buy) 19.3K $3.78M $24.40 Oct 2, 2025 Direct Common Stock
Common Stock 103K $2.22M $21.55 Oct 1, 2025 By John M. Evans, III 2018 Irrevocable Trust

Transactions reported by John M. Evans for Beam Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.